Skip to main content
TipRanks
Go Ultimate75% OFF

Atrium Therapeutics, Inc. (RNA) Cash flow

25 Followers

Atrium Therapeutics, Inc. Cash Flow

RNA's free cash flow for Q3 2026 was $-25.78M. For the 2026 fiscal year, RNA's free cash flow was decreased by $-415.00K and operating cash flow was $-25.37M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -41.13M$ -300.87M$ -119.06M$ -136.27M$ -94.81M
$ -1.45M$ -854.20M$ -130.07M$ -189.96M$ -82.52M
$ 42.57M$ 1.19B$ 93.86M$ 346.17M$ 176.32M
$ 0.00$ 222.66M$ 185.38M$ 340.65M$ 320.70M
$ -42.57M$ -307.94M$ -123.29M$ -139.09M$ -98.55M

Currency in USD

Atrium Therapeutics, Inc. Cash Flow

-1B-500M0500M1B1.5B20182019202020212022202320242025OperatingInvestingFinancing